98294601 - ADRENAVERSE

Information

• Trademark
• 98294601

• Source

• Serial Number

  98294601

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  December 01, 2023
  a year ago

• Transaction Date

  April 10, 2025
  5 days ago

• Status Date

  April 08, 2025
  7 days ago

• Published for Opposition Date

  August 13, 2024
  8 months ago

• Location Date

  October 08, 2024
  6 months ago

• Status Code

  730

• Current Location

  INTENT TO USE SECTION

  Employee Name

  ELLINGER FATHY, JESSICA

• Attorney Docket Number

  407929121670

  Attorney Name

  Carrie Webb Olson

  Law Office Assigned Location Code

  M10

• Owners

  • MONOSOL RX, LLC

Case File Statements

• DM0000: The mark consists of the word "AdrenaVerse" in stylized form with an arched series of 5 shaded circles of descending size extending from the top of the first letter "A" in "AdrenaVerse" and ending at the first letter "E", with the shaded circle above the "A" in the design of a pill.
• GS0051: Technologies in the nature of pharmaceutical preparations containing prodrugs of epinephrine for the treatment or prevention of a wide-range of conditions, namely, anaphylaxis, asthma, and allergic reactions; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery platform technology, namely, drug delivery agents consisting of prodrugs of epinephrine that facilitate, enhance or promote optimized delivery, dosing management and accuracy, enhanced solubility, enhanced permeability, or enhanced absorption of a wide range of pharmaceutical agents
• PM0001: ADRENA VERSE
• CC0000: Color is not claimed as a feature of the mark.
• GS0421: Development of pharmaceutical preparations and medicines; Technology research in the field of pharmaceutical preparations and drug delivery agents; development of drug delivery agents that facilitate the delivery of pharmaceuticals and pharmaceutical preparations

Case File Event Statements

• 2/25/2024 - a year ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSM

• 12/1/2023 - a year ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 7/6/2024 - 9 months ago

  5 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 2/25/2024 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 6/29/2024 - 9 months ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 7/24/2024 - 8 months ago

  6 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 7/26/2024 - 8 months ago

  7 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 7/26/2024 - 8 months ago

  8 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 7/26/2024 - 8 months ago

  9 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 10/8/2024 - 6 months ago

  13 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 7/26/2024 - 8 months ago

  10 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Type: EWAF

• 8/13/2024 - 8 months ago

  11 - PUBLISHED FOR OPPOSITION Type: PUBO

• 8/13/2024 - 8 months ago

  12 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 4/8/2025 - 7 days ago

  14 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 4/8/2025 - 7 days ago

  15 - SOU EXTENSION 1 FILED Type: EXT1

• 4/8/2025 - 7 days ago

  16 - SOU EXTENSION 1 GRANTED Type: EX1G

• 4/9/2025 - 6 days ago

  17 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA